Olga Obrezanova

Dr. Olga Obrezanova is an AI Principal Scientist in the Augmented Biologics Design group at Biologics Engineering, AstraZeneca, based in Cambridge, UK. With 20 years of experience, Olga specializes in applying machine learning & artificial intelligence and developing computational tools for biologics and small molecules drug discovery. Her work is focused on preclinical immunogenicity assessment of biologics and advancing in silico approaches for predicting immunogenicity and developability.